ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,971Medicare Part D Prescriptions Filled, Including Refills

Rank: 1346 out of 5176

$512K Total Retail Price of All Prescriptions

Rank: 1118 out of 5176

334 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 334 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 334 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 5,434 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 256 230 1 2
GLIPIZIDE 194 175 2 63
LEVOTHYROXINE SODIUM 182 120 3 4
METFORMIN HCL 175 151 4 7
LOVASTATIN 174 169 5 46
FUROSEMIDE 171 145 6 8
METOPROLOL TARTRATE 169 138 7 6
ATENOLOL 167 157 8 12
OMEPRAZOLE 162 135 9 3
LOSARTAN POTASSIUM 160 146 10 14
ZOLPIDEM TARTRATE 116 72 11 17
SIMVASTATIN 109 95 12 1
LOSARTAN-HYDROCHLOROTHIAZIDE 106 100 13 35
WARFARIN SODIUM 101 95 14 13
SINGULAIR 101 74 14 62
MELOXICAM 92 76 16 53
TAMSULOSIN HCL 86 80 17 20
CITALOPRAM HBR 78 44 18 31
LISINOPRIL 74 61 19 5
AMLODIPINE BESYLATE-BENAZEPRIL 74 69 19 55
ATORVASTATIN CALCIUM 72 59 21 9
PANTOPRAZOLE SODIUM 71 67 22 61
BENICAR 68 61 23 100
HYDROCODONE-ACETAMINOPHEN 67 47 S3 24 27
LEVOFLOXACIN 67 52 24 109
JANUVIA 66 53 26 25
NEXIUM 62 21 27 16
FOSINOPRIL SODIUM 61 43 28 105
PLAVIX 60 51 29 29
CLOTRIMAZOLE-BETAMETHASONE 60 54 29 94
SYNTHROID 59 39 31 33
PAROXETINE HCL 57 47 32 93
ADVAIR DISKUS 57 41 32 32
OXYCODONE HCL 57 13 S2 32 121
NOVOLOG FLEXPEN 56 19 35 196
METOPROLOL SUCCINATE 55 52 36 11
CLOPIDOGREL 54 44 37 26
JANUMET 52 29 38 77
HYDROCHLOROTHIAZIDE 52 39 38 10
ISOSORBIDE MONONITRATE ER 50 50 40 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.